Meeting slides
Suggested Readings

Abuse rates and routes of administration of reformulated extended-release oxycodone: initial findings from a sentinel surveillance sample of individuals assessed for substance abuse treatment

Butler SF, Cassidy TA, Chilcoat H, et al. J Pain. 2013;14(4):351-358.

Establishing "best practices" for opioid rotation: conclusions of an expert panel

Fine PG, Portenoy RK; Ad Hoc Expert Panel on Evidence Review and Guidelines for Opioid Rotation. J Pain Symptom Manage. 2009;38(3):418-425.

Universal precautions in pain medicine: a rational approach to the treatment of chronic pain

Gourlay DL, Heit HA, Almahrezi A. Pain Med. 2005;6(2):107-112.

Urine drug testing in pain medicine

Heit HA, Gourlay DL. J Pain Symptom Manage. 2004;27(3):260-267.

Substance misuse treatment for high-risk chronic pain patients on opioid therapy: a randomized trial

Jamison RN, Ross EL, Michna E, et al. Pain. 2010;150(3):390-400.

Assessment and treatment of abuse risk in opioid prescribing for chronic pain

Jamison RN, Serraillier J, Michna E. Pain Res Treat. 2011;2011:941808.

Rates of opioid dispensing and overdose after introduction of abuse-deterrent extended-release oxycodone and withdrawal of propoxyphene

Larochelle MR, Zhang F, Ross-Degnan D, Wharam JF. JAMA Intern Med. 2015;175(6):978-987

Abuse-deterrent formulations: part 2: commercial products and proprietary technologies

Mastropietro DJ, Omidian H. Expert Opin Pharmacother. 2015;16(3):305-323.

A review of abuse-deterrent opioids for chronic nonmalignant pain

Moorman-Li R, Motycka CA, Inge LD, et al. P T. 2012;37(7):412-418.

Abuse-deterrent formulations, an evolving technology against the abuse and misuse of opioid analgesics

Schaeffer T. J Med Toxicol. 2012;8(4):400-407.

Linked Resources

Clinical Tools

Brief Pain Inventory (Short Form)

A multidimensional pain assessment instrument that can be used to characterize several aspects of a patient’s pain experience, the short form is also widely used for clinical trials and has been translated into multiple languages.

Opioid Risk Tool

This five-question clinical interview or patient questionnaire helps stratify patients based on their risk for opioid-related misuse and abuse.

Current Opioid Misuse Measure (COMM)®

A 17-item assessment questionnaire, the COMM focuses on current behaviors and cognition rather than character and personality traits associated with risks for substance abuse.

Pain Assessment and Documentation Tool (PADT™)

Completed via clinician-directed interview, this instrument provides a consistent and structured method to document progress with opioid therapy over time.


American Pain Society and American Academy of Pain Medicine: Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain

Chou R, Fanciullo GJ, Fine PG, et al. J Pain. 2009;10(2):113-130.

Department of Veterans Affairs and Department of Defense: Clinical Practice Guideline for Management of Opioid Therapy for Chronic Pain

The Management of Opioid Therapy for Chronic Pain Working Group. Washington, DC: Department of Veterans Affairs, Department of Defense; 2010.

Other Resources

A Clinical Guide to Opioid Analgesia. 2nd edition

Fine PG, Portenoy RK. New York, NY: Vendome Group, LLC; 2007.

Responsible Opioid Prescribing: A Clinician’s Guide. 2nd edition, revised and expanded

Fishman SM. Washington, DC: Waterford Life Sciences; 2012.

Related activities
1.00 CME/CE

Clinical Issues in Chronic Pain

Consensus and Controversies for Responsible Opioid Prescribing

Faculty: Charles Argoff, MD; Jeffrey Gudin, MD; Steven Stanos, DO
Release: 01/11/2016
Expiration: 01/11/2017